Clinical Trials
5 trialsNCT07582887 2026-05-13
Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Recruiting
NCT07251868 2025-11-26
Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study
Peking University Cancer Hospital & Institute
Recruiting
NCT06504719 2025-09-15
Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan
Hellenic Cooperative Oncology Group
Completed
NCT06991790 2025-05-28
Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration
Peking University Cancer Hospital & Institute
Recruiting
NCT06356519 2024-04-10
Real-world Effectiveness and Safety Study of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer
Fudan University
Unknown